Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
6
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
6
×
national top stories
6
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
6
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
deals
amag pharmaceuticals
europe blog main
europe top stories
investing
pfizer
regeneron pharmaceuticals
alzheimer's disease
arch venture partners
astrazeneca
What
roundup
bio
develop
amid
bombast
cancer
caught
coronavirus
debate
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
according
acquisitions
akcea
alliance
announced
bails
biotech
brand
bridgebio
bristol
buy
calls
capital
car
cases
centers
ceo
changing
cigarettes
Language
unset
6
×
Current search:
startups
×
unset
×
" national blog main "
×
" national top stories "
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More